Oral Contraceptive Containing Chlormadinone Acetate and Ethinylestradiol Reduces Plasma Concentrations of Matrix Metalloproteinase-2 in Women with Polycystic Ovary Syndrome-Reference-Cited by-同舟云学术

Oral Contraceptive Containing Chlormadinone Acetate and Ethinylestradiol Reduces Plasma Concentrations of Matrix Metalloproteinase-2 in Women with Polycystic Ovary Syndrome

Published:2012-05 Issue: Volume: Page:n/a-n/a
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Gomes Valéria A.¹,Vieira Carolina S.,Jacob-Ferreira Anna L.¹,Belo Vanessa A.¹,Soares Gustavo M.²,França Janaína B.²,Ferriani Rui A.,Tanus-Santos Jose E.³

Affiliation:

1. Department of Pharmacology; Faculty of Medical Sciences; State University of Campinas; Campinas; SP; Brazil

2. Department of Gynecology and Obstetrics; Faculty of Medicine of Ribeirão Preto; University of São Paulo; Ribeirão Preto; SP; Brazil

3. Department of Pharmacology; Faculty of Medicine of Ribeirão Preto; University of São Paulo; Ribeirão Preto; SP; Brazil

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Reference52 articles.

1. Inflammatory and endothelial markers in women with polycystic ovary syndrome;Diamanti-Kandarakis;Eur J Clin Invest,2006

2. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment;Heutling;J Clin Endocrinol Metab,2008

3. Evidence of proatherogenic inflammation in polycystic ovary syndrome;Gonzalez;Metabolism,2009

4. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome;Vural;Hum Reprod,2005

5. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome;Orio;J Clin Endocrinol Metab,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral contraceptives and stroke: Foes or friends;Frontiers in Neuroendocrinology;2022-10

2. Treatments;Managing Women’s Hyperandrogenism;2019-10-04

3. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome;Reproductive Biology and Endocrinology;2017-12

4. Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies;Gynecological Endocrinology;2014-09-25